Literature DB >> 2768389

Automated liquid chromatographic analysis of drugs in urine by on-line sample cleanup and isocratic multi-column separation.

S R Binder1, M Regalia, M Biaggi-McEachern, M Mazhar.   

Abstract

A multi-column system has been developed for automated analysis of basic drugs in urine. Two polymeric pre-columns, containing PRP-1 and Aminex A-28, were used to isolate the drugs. A short reversed-phase column, coupled to a 150 x 4.6 mm I.D. silica column, produced the analytical separation. Sample preparation consisted of dilution and centrifugation. The entire procedure required less than 30 min. Careful optimization of mobile phase conditions led to retention of benzoylecgonine and barbiturates. For most drugs, levels of 0.3 mg/l were sufficient to produce peaks that could be matched against stored spectra with a computerized library search program.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2768389     DOI: 10.1016/s0021-9673(00)91317-7

Source DB:  PubMed          Journal:  J Chromatogr


  4 in total

1.  Scope and limitations of a general unknown screening by gas chromatography-mass spectrometry in acute poisoning.

Authors:  C Köppel; J Tenczer
Journal:  J Am Soc Mass Spectrom       Date:  1995-11       Impact factor: 3.109

2.  Performance evaluation of three liquid chromatography mass spectrometry methods for broad spectrum drug screening.

Authors:  Kara L Lynch; Autumn R Breaud; Hilde Vandenberghe; Alan H B Wu; William Clarke
Journal:  Clin Chim Acta       Date:  2010-06-09       Impact factor: 3.786

3.  Determination of benzodiazepines in clinical serum samples: comparative evaluation of REMEDi system, aca analyzer, and conventional HPLC performance.

Authors:  T L Chang; K W Chen; Y D Lee; K Fan
Journal:  J Clin Lab Anal       Date:  1999       Impact factor: 2.352

4.  High prevalence of unknown co-medication in hospitalised patients.

Authors:  Karin Rieger; André Scholer; Isabelle Arnet; Frank T Peters; Hans H Maurer; Ingeborg Walter-Sack; Walter E Haefeli; Meret Martin-Facklam
Journal:  Eur J Clin Pharmacol       Date:  2004-06-10       Impact factor: 2.953

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.